← Open Payments lookup

DANIEL FEENEY: Open Payments

NPI 1326012949 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,326 in 67 payments from 13 companies in 2025. Trend: 2023 $1,463 · 2024 $968 · 2025 $1,326

Food & beverage: $1,326
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$331
ABBVIE INC.10$193
Teva Pharmaceuticals USA, Inc.5$123
Otsuka America Pharmaceutical, Inc.5$109
Janssen Pharmaceuticals, Inc5$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$98
Lundbeck LLC4$83
Alkermes, Inc.4$78
LivaNova USA, Inc.2$76
Collegium Pharmaceutical, Inc.3$46

Products named: INGREZZA, VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA, ARISTADA, AUSTEDO XR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR.

Industry payments across LA — which companies pay providers there.